Evidence map›Paper›PMID 24886557›Full record

ArticleParasites & vectors2014

Anti-feeding efficacy of Activyl® Tick Plus topical treatment of dogs against Phlebotomus perniciosus.

Régis Frenais, Annie Flochlay-Sigognault, Gaëlle Milon-Harnois

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Régis FrenaisMSD Animal Health Innovation SAS, 7 rue Olivier de Serres, CS 67131, Beaucouzé cedex 49071, France. regis.frenais@merck.com.
Annie Flochlay-Sigognault
Gaëlle Milon-Harnois
Département Santé Animale · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTopical permethrin treatment is known to prevent feeding of sandflies on dogs. This study investigated the anti-feeding efficacy and the immediate insecticidal efficacy (knock-down effect) of topical treatment of dogs with a new commercially available combination of indoxacarb and permethrin (Activyl® Tick Plus), compared with a negative control.

methodsSedated dogs were individually exposed to unfed female sandflies in a darkened chamber for one hour 2, 7, 14, 21 and 29 days after treatment. Mean fly feeding and survival rates in the two groups after one hour of exposure were used to calculate the anti-feeding efficacy and the knock-down effect, respectively.

resultsOn Days 2, 7, 14, 21 and 29 post treatment, the anti-feeding efficacy was 99, 98, 96, 88 and 84% based on geometric means. The mean number of fed sandflies in the treated group was significantly lower than in the control group mean at every evaluation time point. The knock-down effect, measured at one hour after exposure of the flies to treated dogs, was 32, 27, 9, 0 and 4% based on geometric means, at the same time points. The number of dead flies was significantly higher in the treated group on Days 2 and 7 post-treatment. No adverse effects of treatment were observed at any time during the study.

conclusionsActivyl® Tick Plus treatment of dogs provided a high anti-feeding efficacy against Phlebotomus perniciosus from 2 to 21 days post treatment, with continuing significant anti-feeding to 29 days post-treatment, and was well tolerated. Some knock-down effect following one hour of exposure of flies to treated dogs was observed in the first week after treatment.

Indexed as

DogsAdministration, TopicalAnimalsDog DiseasesDrug Therapy, CombinationFeeding BehaviorFemaleInsect Bites and StingsInsecticidesMaleOxazinesPermethrinPhlebotomusindoxacarbInsecticidesOxazinesPermethrin

Identifiers

PMID24886557
PMCPMC4030270
OpenAlexW2114683886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.